Please provide your email address to receive an email when new articles are posted on . Nondiabetic adults with insulin resistance and obesity saw improved fasting glucose levels and decreased free ...

European Union (EU) regulators today recommended narrowing the indication for drugs containing the lipid-lowering agent acipimox. Acipimox should be used only as an additional or alternative treatment ...

Please provide your email address to receive an email when new articles are posted on . Men with type 2 diabetes who received acipimox as an add-on to 3 weeks of Farxiga therapy saw improved beta-cell ...